Published in Diabetologia on January 04, 2006
Standards of medical care in diabetes--2013. Diabetes Care (2013) 24.85
Standards of medical care in diabetes--2010. Diabetes Care (2010) 24.28
Standards of medical care in diabetes--2011. Diabetes Care (2011) 21.94
Standards of medical care in diabetes--2012. Diabetes Care (2012) 20.66
Standards of medical care in diabetes--2009. Diabetes Care (2009) 15.78
10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet (2009) 15.00
Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care (2011) 6.48
Prediabetes: a high-risk state for diabetes development. Lancet (2012) 6.42
Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet (2016) 4.80
Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet (2012) 4.33
Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement. Diabetes Care (2010) 3.98
Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore. BMJ (2009) 3.68
Systematic review of reviews of intervention components associated with increased effectiveness in dietary and physical activity interventions. BMC Public Health (2011) 3.55
Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force. Ann Intern Med (2015) 3.11
Global obesity: trends, risk factors and policy implications. Nat Rev Endocrinol (2012) 3.09
Reduction in the incidence of type 2 diabetes with the Mediterranean diet: results of the PREDIMED-Reus nutrition intervention randomized trial. Diabetes Care (2010) 3.07
The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia (2009) 3.05
Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men. Proc Natl Acad Sci U S A (2006) 2.88
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet (2013) 2.66
Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis. BMJ (2008) 2.63
The role of physical activity in the management of impaired glucose tolerance: a systematic review. Diabetologia (2007) 2.51
Lifestyle intervention for prevention of type 2 diabetes in primary health care: one-year follow-up of the Finnish National Diabetes Prevention Program (FIN-D2D). Diabetes Care (2010) 2.50
Cost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review. Diabetes Care (2010) 2.49
A1C level and future risk of diabetes: a systematic review. Diabetes Care (2010) 2.35
Adherence to Mediterranean diet and risk of developing diabetes: prospective cohort study. BMJ (2008) 2.33
The prevention of type 2 diabetes. Nat Clin Pract Endocrinol Metab (2008) 2.27
Treating prediabetes with metformin: systematic review and meta-analysis. Can Fam Physician (2009) 2.18
Metformin prescription for insured adults with prediabetes from 2010 to 2012: a retrospective cohort study. Ann Intern Med (2015) 2.16
Maternal metabolism and obesity: modifiable determinants of pregnancy outcome. Hum Reprod Update (2009) 2.11
Trends in prevalence of diabetes in Asian countries. World J Diabetes (2012) 1.96
Dietary weight loss and exercise effects on insulin resistance in postmenopausal women. Am J Prev Med (2011) 1.90
Assessing the knowledge, attitudes and practice of type 2 diabetes among patients of Saurashtra region, Gujarat. Int J Diabetes Dev Ctries (2009) 1.84
Serum vitamin-D predicts insulin resistance in individuals with prediabetes. Indian J Med Res (2013) 1.81
Long-term safety, tolerability, and weight loss associated with metformin in the Diabetes Prevention Program Outcomes Study. Diabetes Care (2012) 1.78
Prevention and management of type 2 diabetes: dietary components and nutritional strategies. Lancet (2014) 1.75
Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study--secondary analysis of the randomized trial. PLoS One (2009) 1.68
Spousal diabetes as a diabetes risk factor: a systematic review and meta-analysis. BMC Med (2014) 1.59
Use of HbA1c for diagnoses of diabetes and prediabetes: comparison with diagnoses based on fasting and 2-hr glucose values and effects of gender, race, and age. Metab Syndr Relat Disord (2014) 1.53
Long-term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study. Diabet Med (2013) 1.51
The rising burden of diabetes and hypertension in southeast asian and african regions: need for effective strategies for prevention and control in primary health care settings. Int J Hypertens (2013) 1.50
Effect of intervention in subjects with high risk of diabetes mellitus in pakistan. J Nutr Metab (2012) 1.47
Secondary failure of metformin monotherapy in clinical practice. Diabetes Care (2009) 1.46
Reduction of diabetes risk in routine clinical practice: are physical activity and nutrition interventions feasible and are the outcomes from reference trials replicable? A systematic review and meta-analysis. BMC Public Health (2010) 1.46
Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes. Metabolism (2011) 1.41
The economic costs of diabetes: is it time for a new treatment paradigm? Diabetes Care (2013) 1.38
Independent and combined effects of exercise training and metformin on insulin sensitivity in individuals with prediabetes. Diabetes Care (2011) 1.38
Convergence of prevalence rates of diabetes and cardiometabolic risk factors in middle and low income groups in urban India: 10-year follow-up of the Chennai Urban Population Study. J Diabetes Sci Technol (2011) 1.36
Treating type 2 diabetes mellitus with traditional chinese and Indian medicinal herbs. Evid Based Complement Alternat Med (2013) 1.34
Metformin: an old but still the best treatment for type 2 diabetes. Diabetol Metab Syndr (2013) 1.31
Type 2 diabetes can be prevented with early pharmacological intervention. Diabetes Care (2011) 1.31
Postpartum screening for diabetes among women with a history of gestational diabetes mellitus. Prev Chronic Dis (2011) 1.27
Economic evaluation of lifestyle interventions for preventing diabetes and cardiovascular diseases. Int J Environ Res Public Health (2010) 1.27
Can diabetes prevention programmes be translated effectively into real-world settings and still deliver improved outcomes? A synthesis of evidence. Diabet Med (2013) 1.26
Metabolic syndrome in South Asians. Indian J Endocrinol Metab (2012) 1.24
Hypothetical midlife interventions in women and risk of type 2 diabetes. Epidemiology (2013) 1.23
Incorporation of whole, ancient grains into a modern Asian Indian diet to reduce the burden of chronic disease. Nutr Rev (2011) 1.23
Defining obesity cut-off points for migrant South Asians. PLoS One (2011) 1.22
Nonpharmacologic therapy and exercise in the prevention of type 2 diabetes. Diabetes Care (2009) 1.22
Lifestyle interventions in primary care: systematic review of randomized controlled trials. Can Fam Physician (2008) 1.22
Pathophysiologic differences among Asians, native Hawaiians, and other Pacific Islanders and treatment implications. Diabetes Care (2012) 1.21
Type II Diabetes Mellitus in Arabic-Speaking Countries. Int J Endocrinol (2012) 1.18
Long-term benefits from lifestyle interventions for type 2 diabetes prevention: time to expand the efforts. Diabetes Care (2011) 1.18
Importance of weight loss maintenance and risk prediction in the prevention of type 2 diabetes: analysis of European Diabetes Prevention Study RCT. PLoS One (2013) 1.16
Prevention of type 2 diabetes in adults with impaired glucose tolerance: the European Diabetes Prevention RCT in Newcastle upon Tyne, UK. BMC Public Health (2009) 1.16
High prevalence of obesity, central obesity and abnormal glucose tolerance in the middle-aged Finnish population. BMC Public Health (2008) 1.15
Pretransplant risk score for new-onset diabetes after kidney transplantation. Diabetes Care (2011) 1.13
Changes in insulin secretion and insulin sensitivity in relation to the glycemic outcomes in subjects with impaired glucose tolerance in the Indian Diabetes Prevention Programme-1 (IDPP-1). Diabetes Care (2009) 1.13
Preventing diabetes in American Indian communities. Diabetes Care (2013) 1.12
Can new-onset diabetes after kidney transplant be prevented? Diabetes Care (2013) 1.10
Prevention of type 2 diabetes in a primary healthcare setting: three-year results of lifestyle intervention in Japanese subjects with impaired glucose tolerance. BMC Public Health (2011) 1.10
Prevention of type 2 diabetes and its complications in developing countries: a review. Int J Behav Med (2012) 1.09
The Sydney Diabetes Prevention Program: a community-based translational study. BMC Public Health (2010) 1.08
Feasibility of group lifestyle intervention for diabetes prevention in Arab Americans. Diabetes Res Clin Pract (2010) 1.08
Early response to preventive strategies in the Diabetes Prevention Program. J Gen Intern Med (2013) 1.06
Prediabetes diagnosis and treatment: A review. World J Diabetes (2015) 1.05
Prevention & control of CVD in women & children in India. Indian J Med Res (2013) 1.03
Relationship between inpatient hyperglycemia and insulin treatment after kidney transplantation and future new onset diabetes mellitus. Clin J Am Soc Nephrol (2010) 1.03
Lifestyle change in Kerala, India: needs assessment and planning for a community-based diabetes prevention trial. BMC Public Health (2013) 1.02
Type 2 diabetes: identifying high risk Asian American subgroups in a clinical population. Diabetes Res Clin Pract (2011) 1.02
Animal models of GWAS-identified type 2 diabetes genes. J Diabetes Res (2013) 1.01
A systematic review of real-world diabetes prevention programs: learnings from the last 15 years. Implement Sci (2015) 1.01
Therapeutic interventions to reduce the risk of progression from prediabetes to type 2 diabetes mellitus. Ther Clin Risk Manag (2014) 1.00
Pigment epithelium-derived factor suppresses adipogenesis via inhibition of the MAPK/ERK pathway in 3T3-L1 preadipocytes. Am J Physiol Endocrinol Metab (2009) 1.00
The economics of diabetes prevention. Med Clin North Am (2011) 0.99
Economic Evaluation of Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force. Ann Intern Med (2015) 0.99
Mediterranean diet and health: food effects on gut microbiota and disease control. Int J Mol Sci (2014) 0.98
Let's prevent diabetes: study protocol for a cluster randomised controlled trial of an educational intervention in a multi-ethnic UK population with screen detected impaired glucose regulation. Cardiovasc Diabetol (2012) 0.98
Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors' Expert Forum. Diabetes Care (2016) 0.97
Management of NCD in low- and middle-income countries. Glob Heart (2014) 0.97
Diabetes and associated complications in the South Asian population. Curr Cardiol Rep (2014) 0.95
Mechanistic studies of lifestyle interventions in type 2 diabetes. World J Diabetes (2012) 0.95
Cost-effectiveness analysis of efforts to reduce risk of type 2 diabetes and cardiovascular disease in southwestern Pennsylvania, 2005-2007. Prev Chronic Dis (2010) 0.94
Factors influencing participation in a vascular disease prevention lifestyle program among participants in a cluster randomized trial. BMC Health Serv Res (2013) 0.94
Susceptibility to type 2 diabetes mellitus--from genes to prevention. Nat Rev Endocrinol (2014) 0.94
Implications of rising prediabetes prevalence. Diabetes Care (2013) 0.94
Built environment and diabetes. Int J Diabetes Dev Ctries (2010) 0.93
Steps to preventing type 2 diabetes: exercise, walk more, or sit less? Front Endocrinol (Lausanne) (2012) 0.93
Insulin secretion and its determinants in the progression of impaired glucose tolerance to type 2 diabetes in impaired glucose-tolerant individuals: the Finnish Diabetes Prevention Study. Diabetes Care (2011) 0.93
Is Diabetes Becoming the Biggest Epidemic of the Twenty-first Century? Int J Health Sci (Qassim) (2007) 0.92
Feasibility and effectiveness of a targeted diabetes prevention program for 18 to 60-year-old South Asian migrants: design and methods of the DH!AAN study. BMC Public Health (2012) 0.92
High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia (2001) 5.79
Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem (1995) 4.53
Rising prevalence of NIDDM in an urban population in India. Diabetologia (1997) 3.03
Temporal changes in prevalence of diabetes and impaired glucose tolerance associated with lifestyle transition occurring in the rural population in India. Diabetologia (2004) 2.32
Metabolic syndrome in urban Asian Indian adults--a population study using modified ATP III criteria. Diabetes Res Clin Pract (2003) 2.27
Age- and sex-specific prevalence of diabetes and impaired glucose regulation in 11 Asian cohorts. Diabetes Care (2003) 2.18
Patients' adherence to diabetes treatment. J Assoc Physicians India (1999) 2.10
High prevalence of diabetes in an urban population in south India. BMJ (1988) 1.90
Prevalence of overweight in urban Indian adolescent school children. Diabetes Res Clin Pract (2002) 1.80
Prevalence of glucose intolerance in Asian Indians. Urban-rural difference and significance of upper body adiposity. Diabetes Care (1992) 1.73
Derivation and validation of diabetes risk score for urban Asian Indians. Diabetes Res Clin Pract (2005) 1.66
Incidence of IDDM in children in urban population in southern India. Madras IDDM Registry Group Madras, South India. Diabetes Res Clin Pract (1996) 1.56
Expenditure on health care incurred by diabetic subjects in a developing country--a study from southern India. Diabetes Res Clin Pract (2000) 1.55
Impacts of urbanisation on the lifestyle and on the prevalence of diabetes in native Asian Indian population. Diabetes Res Clin Pract (1999) 1.48
The genetic predisposition to fibrocalculous pancreatic diabetes. Diabetologia (1989) 1.46
High prevalence of cardiometabolic risk factors among young physicians in India. J Assoc Physicians India (2008) 1.45
Combination therapy of glibenclamide and insulin in NIDDM patients with secondary failure to oral drugs. J Assoc Physicians India (1990) 1.40
Impact of poverty on the prevalence of diabetes and its complications in urban southern India. Diabet Med (2002) 1.40
Influence of life style factors in development of diabetes in Indians--scope for primary prevention. J Assoc Physicians India (1999) 1.39
Foot care economics--cost burden to diabetic patients with foot complications: a study from southern India. J Assoc Physicians India (2001) 1.39
GAD65 antibodies in classification of Asian Indian diabetic subjects with onset between 20 and 40 years. Diabetes Care (1999) 1.38
Clustering of cardiovascular risk factors in urban Asian Indians. Diabetes Care (1998) 1.33
Risk of noninsulin dependent diabetes mellitus conferred by obesity and central adiposity in different ethnic groups: a comparative analysis between Asian Indians, Mexican Americans and Whites. Diabetes Res Clin Pract (1997) 1.28
Awareness about diabetes and its complications in the general and diabetic population in a city in southern India. Diabetes Res Clin Pract (2007) 1.28
Stress and undetected hyperglycemia in southern Indian coastal population affected by tsunami. J Assoc Physicians India (2006) 1.26
Age-specific prevalence and risk associations for impaired glucose tolerance in urban southern Indian population. J Assoc Physicians India (2003) 1.23
Need for education on footcare in diabetic patients in India. J Assoc Physicians India (1999) 1.23
Temporal changes in prevalence of type 2 diabetes and impaired glucose tolerance in urban southern India. Diabetes Res Clin Pract (2002) 1.21
Changes in the carboxyl-terminal domain of metabotropic glutamate receptor 1 by alternative splicing generate receptors with differing agonist-independent activity. Mol Pharmacol (1996) 1.21
Significance of impaired glucose tolerance in an Asian Indian population: a follow-up study. Diabetes Res Clin Pract (1986) 1.18
Risk variables for coronary artery disease in Asian Indians. Am J Cardiol (2001) 1.17
Prevalence of childhood diabetes in an urban population in south India. Diabetes Res Clin Pract (1992) 1.16
Low risk threshold for acquired diabetogenic factors in Asian Indians. Diabetes Res Clin Pract (2004) 1.15
Familial aggregation of type 2 (non-insulin-dependent) diabetes mellitus in south India; absence of excess maternal transmission. Diabet Med (1996) 1.14
Costs incurred by families having Type 1 diabetes in a developing country--a study from Southern India. Diabetes Res Clin Pract (2002) 1.07
High prevalence of maturity-onset diabetes of the young (MODY) among Indians. Diabetes Care (1985) 1.05
High prevalence of type 2 (non-insulin-dependent) diabetes among the offspring of conjugal type 2 diabetic parents in India. Diabetologia (1985) 1.05
Comparative study of monocomponent insulins and conventional insulins on the course of diabetic nephropathy. A follow-up study. J Assoc Physicians India (1990) 1.05
Cost burden to diabetic patients with foot complications--a study from southern India. J Assoc Physicians India (2000) 1.05
Colovaginal and colovesical fistulae: the diagnostic paradigm. Tech Coloproctol (2012) 1.04
Phenylglycine derivatives discriminate between mGluR1- and mGluR5-mediated responses. Neuropharmacology (1995) 1.04
Prevalence of pathogens in diabetic foot infection in South Indian type 2 diabetic patients. J Assoc Physicians India (2002) 1.04
Association between ACE gene polymorphism and diabetic nephropathy in South Indian patients. JOP (2001) 1.03
Cdc42Hs and Rac1 GTPases induce the collapse of the vimentin intermediate filament network. J Biol Chem (2000) 1.03
Pioglitazone does not enhance the effectiveness of lifestyle modification in preventing conversion of impaired glucose tolerance to diabetes in Asian Indians: results of the Indian Diabetes Prevention Programme-2 (IDPP-2). Diabetologia (2009) 1.02
Primary prevention of Type 2 diabetes in South Asians--challenges and the way forward. Diabet Med (2013) 1.02
Micronutrient antioxidant status in tropical compared with temperate-zone chronic pancreatitis. Scand J Gastroenterol (1993) 1.02
[Psychiatric manifestations of vitamin B12 deficiency: a case report]. Encephale (2004) 1.01
Allelic variation in the vitamin D receptor influences susceptibility to IDDM in Indian Asians. Diabetologia (1997) 0.99
Vascular complications in young Asian Indian patients with type 1 diabetes mellitus. Diabetes Res Clin Pract (2000) 0.98
Diabetic retinopathy at the time of diagnosis of NIDDM in south Indian subjects. Diabetes Res Clin Pract (1996) 0.98
Insulin secretion and action show differences in impaired fasting glucose and in impaired glucose tolerance in Asian Indians. Diabetes Metab Res Rev (2003) 0.97
An uncoupling protein 2 gene variant is associated with a raised body mass index but not Type II diabetes. Diabetologia (1999) 0.97
Impaired fasting glucose and impaired glucose tolerance in urban population in India. Diabet Med (2003) 0.96
Evaluation of the use of fasting plasma glucose as a new diagnostic criterion for diabetes in Asian Indian population. Diabetes Care (1998) 0.96
Diabetes in South Asians. Diabet Med (2014) 0.96
Prevalence of vascular complications and their risk factors in type 2 diabetes. J Assoc Physicians India (1999) 0.95
MAST system: a new condensed cardiopulmonary bypass circuit for adult cardiac surgery. Perfusion (2001) 0.95
Diabetes prevention programs. Med Clin North Am (2011) 0.94
Prevalence of non-insulin-dependent diabetes mellitus in Asian Indian families with a single diabetic parent. Diabetes Res Clin Pract (1988) 0.94
Tropical pancreatic diabetes in South India: heterogeneity in clinical and biochemical profile. Diabetologia (1985) 0.94
Peripheral neuropathy in tropical pancreatic diabetes. Acta Diabetol Lat (1986) 0.92
Coupling of metabotropic glutamate receptors 2 and 4 to G alpha 15, G alpha 16, and chimeric G alpha q/i proteins: characterization of new antagonists. Mol Pharmacol (1996) 0.92
High prevalence of NIDDM and IGT in an elderly south Indian population with low rates of obesity. Diabetes Care (1994) 0.91
Quality of life and diabetes integration among subjects with type 2 diabetes. J Assoc Physicians India (2003) 0.91
mGluR7-like metabotropic glutamate receptors inhibit NMDA-mediated excitotoxicity in cultured mouse cerebellar granule neurons. Eur J Neurosci (1999) 0.91
Familial aggregation of diabetic kidney disease in Type 2 diabetes in south India. Diabetes Res Clin Pract (1999) 0.91
Cosegregation of obesity with familial aggregation of type 2 diabetes mellitus. Diabetes Obes Metab (2000) 0.91
Prevalence of proteinuria in non-insulin dependent diabetes. J Assoc Physicians India (1994) 0.90
Population based study of quality of diabetes care in southern India. J Assoc Physicians India (2008) 0.90
Immediate impact of a diabetes training programme for primary care physicians--an endeavour for national capacity building for diabetes management in India. Diabetes Res Clin Pract (2008) 0.90
Insulin and C-peptide responses to glucose load in cystic fibrosis. Diabete Metab (1985) 0.89
Insulin resistance alone does not explain the clustering of cardiovascular risk factors in southern India. Diabet Med (2000) 0.89